EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Virus target inhibition and immune enhancement of cyclobutenamine derivatives against herpes simplex virus type 1

Ying Qu, Xiaoxiao Shen, Chaofeng Zhang, Ruotong Hai, Ziyan Li, Jiejie Lu, Su Lyu, Wenhua Xue, Ranran Sun, Chengyun Jin, Junbiao Chang, Xiaona Wang und 1 weitere

Acta Pharmaceutica Sinica B · 2026-11

DOI: 10.1016/j.apsb.2026.11.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Ying Qu und 12 weiteren Autor:innen. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Henan Province Natural Science Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Henan Province Natural Science Foundation

Zitieren

APA

Qu, Y., Shen, X., Zhang, C., Hai, R., Li, Z., Lu, J., Lyu, S., Xue, W., Sun, R., Jin, C., Chang, J., Wang, X., & Wang, Z. (2026). Virus target inhibition and immune enhancement of cyclobutenamine derivatives against herpes simplex virus type 1. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.11.003

Vancouver

Qu Y, Shen X, Zhang C, Hai R, Li Z, Lu J, et al. Virus target inhibition and immune enhancement of cyclobutenamine derivatives against herpes simplex virus type 1. Acta Pharmaceutica Sinica B. 2026. doi:10.1016/j.apsb.2026.11.003

BibTeX
@article{Qu2026,
  author = {Qu, Ying and Shen, Xiaoxiao and Zhang, Chaofeng and Hai, Ruotong and Li, Ziyan and Lu, Jiejie and Lyu, Su and Xue, Wenhua and Sun, Ranran and Jin, Chengyun and Chang, Junbiao and Wang, Xiaona and Wang, Zhenya},
  title = {Virus target inhibition and immune enhancement of cyclobutenamine derivatives against herpes simplex virus type 1},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  doi = {10.1016/j.apsb.2026.11.003}
}
Kostenlos starten →